Original language | English (US) |
---|---|
Pages (from-to) | 2248-2249 |
Number of pages | 2 |
Journal | Neurology |
Volume | 75 |
Issue number | 24 |
DOIs | |
State | Published - Dec 14 2010 |
ASJC Scopus subject areas
- Clinical Neurology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
An independent replication of park16 in asian samples. / Vilariño-Güell, C.; Ross, O. A.; Aasly, J. O.; White, L. R.; Rajput, A.; Rajput, A. H.; Lynch, T.; Krygowska-Wajs, A.; Jasinska-Myga, B.; Opala, G.; Barcikowska, M.; Lee, M. C.; Hentati, F.; Uitti, R. J.; Wszolek, Z. K.; Farrer, M. J.; Wu, R. M.
In: Neurology, Vol. 75, No. 24, 14.12.2010, p. 2248-2249.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - An independent replication of park16 in asian samples
AU - Vilariño-Güell, C.
AU - Ross, O. A.
AU - Aasly, J. O.
AU - White, L. R.
AU - Rajput, A.
AU - Rajput, A. H.
AU - Lynch, T.
AU - Krygowska-Wajs, A.
AU - Jasinska-Myga, B.
AU - Opala, G.
AU - Barcikowska, M.
AU - Lee, M. C.
AU - Hentati, F.
AU - Uitti, R. J.
AU - Wszolek, Z. K.
AU - Farrer, M. J.
AU - Wu, R. M.
N1 - Funding Information: Study funding: Supported by NIH NINDS P50 NS40256 and the Michael J. Fox Foundation. Funding Information: Disclosure: Dr. Vilarino-Guell reports no disclosures. Dr. Ross serves on the editorial board of Open Longevity Science. Dr. Aasly serves on the editorial boards of Parkinsonism & Related Disorders, Tidsskrift Norske Lægeforening , and Parkinson Disease ; and is coauthor on a patent re: LRRK2 G2019S. Dr. White reports no disclosures. Dr. Alex Rajput has served on scientific advisory boards for Novartis and UCB; has received funding for travel and speaker honoraria from Novartis; serves on the editorial board of the Canadian Journal of Neurological Sciences ; and has received research support from Novartis, Allergan Inc., the NIH (NINDS U01 NS050324-01A1 [local PI]) , CIHR, International Essential Tremor Foundation, Regina Curling Classic for Parkinson's research, and Parkinson's disease and movement disorders endowment through RUH Foundation. Dr. Ali Rajput receives research support from the Saskatchewan Parkinson's Disease Foundation, Curling Classic, and PrintWest Golf Classic. Dr. Lynch serves/has served on scientific advisory boards for Merck Serono, the UK Parkinson's Disease Association, the Dublin Neurological Institute at the Mater Misericordiae University Hospital, the Irish Institute of Clinical Neuroscience, and Neuroscience Ireland; has received speaker honoraria from Lundbeck Inc. and Boehringer Ingelheim; and has received unrestricted educational grants from Orion Corporation, Lundbeck Inc., Boehringer Ingelheim, Bayer Schering Pharma, Biogen Idec, and GlaxoSmithKline for opening of the Dublin Neurological Institute, Ireland. Dr. Krygowska-Wajs reports no disclosures. Dr. Jasinska-Myga has received research support from the Robert and Clarice Smith Fellowship Program, the Pacific Alzheimer Research Foundation, and the Polish Foundation for Development of Neurology, Degenerative and Cerebrovascular Diseases. Dr. Opala serves on the editorial board of Neurologia i Neurochirurgia Polska, Polski Przegląd Neurologiczny, Neurologia po Dyplomie , and Psychogeriatria Polska. Dr. Barcikowska has received speaker honoraria from Novartis. Dr. Lee and Dr. Hentati report no disclosures. Dr. Uitti serves as an Associate Editor of Neurology ®; has received research support from Advanced Neuromodulations Systems and the NIH/NINDS (P50NS 40256 [coinvestigator]) ; and his institution receives annual royalties from Lundbeck Inc. from the licensing of the technology related to PARK8/LRRK2 . Dr. Wszolek serves as Co-Editor-in-Chief of Parkinsonism and Related Disorders , Regional Editor of the European Journal of Neurology , and on the editorial boards of Neurologia i Neurochirurgia Polska, Advances in Rehabilitation , the Medical Journal of the Rzeszow University , and Clinical and Experimental Medical Letters ; holds and has contractual rights for receipt of future royalty payments from patents re: A novel polynucleotide involved in heritable Parkinson's disease; receives royalties from publishing Parkinsonism and Related Disorders (Elsevier, 2007, 2008, 2009) and the European Journal of Neurology (Wiley-Blackwell, 2007, 2008, 2009) ; receives research support from Allergan, Inc., the NIH (NIA P01AG017216-1 [coinvestigator], NIA R01AG015866-1 [coinvestigator], and NINDS P50NS 40256 [coinvestigator]) , the Pacific Alzheimer Research Foundation (Canada), and the CIHR. Dr. Farrer serves on a scientific advisory board for the Michael J. Fox Foundation; serves/has served on the editorial boards of Neurobiology of Disease and Parkinsonism and Related Disorders ; is coinventor on patents re: LRRK2 gene and mutations; receives institutional research support from Lundbeck Inc.; has received research support from the NIH (NS40256 [Project and Core PI]) , the Pacific Alzheimer Research Foundation, and the Michael J. Fox Foundation; and his institution receives annual royalties from Lundbeck Inc. from the licensing of the technology related to PARK8/LRRK2 . Dr. Wu reports no disclosures. Clinical/Scientific Notes
PY - 2010/12/14
Y1 - 2010/12/14
UR - http://www.scopus.com/inward/record.url?scp=78650846243&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78650846243&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e318202031f
DO - 10.1212/WNL.0b013e318202031f
M3 - Article
C2 - 21172849
AN - SCOPUS:78650846243
VL - 75
SP - 2248
EP - 2249
JO - Neurology
JF - Neurology
SN - 0028-3878
IS - 24
ER -